Arterra Bioscience SpA (MIL:ARBS) Gross Margin % : 46.91% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Arterra Bioscience SpA Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Arterra Bioscience SpA's Gross Profit for the six months ended in Jun. 2024 was €1.06 Mil. Arterra Bioscience SpA's Revenue for the six months ended in Jun. 2024 was €2.25 Mil. Therefore, Arterra Bioscience SpA's Gross Margin % for the quarter that ended in Jun. 2024 was 46.91%.

Warning Sign:

Arterra Bioscience SpA gross margin has been in long-term decline. The average rate of decline per year is -2.1%.

The historical rank and industry rank for Arterra Bioscience SpA's Gross Margin % or its related term are showing as below:

MIL:ARBS' s Gross Margin % Range Over the Past 10 Years
Min: 53.03 Med: 65.54 Max: 66.36
Current: 57.22

During the past 7 years, the highest Gross Margin % of Arterra Bioscience SpA was 66.36%. The lowest was 53.03%. And the median was 65.54%.

MIL:ARBS's Gross Margin % is ranked worse than
53.37% of 742 companies
in the Biotechnology industry
Industry Median: 59.805 vs MIL:ARBS: 57.22

Arterra Bioscience SpA had a gross margin of 46.91% for the quarter that ended in Jun. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Arterra Bioscience SpA was -2.10% per year.

Arterra Bioscience SpA Gross Margin % Historical Data

The historical data trend for Arterra Bioscience SpA's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arterra Bioscience SpA Gross Margin % Chart

Arterra Bioscience SpA Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

65.54

66.12

66.36

65.72

53.03

Arterra Bioscience SpA Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Gross Margin %	Get a 7-Day Free Trial									75.41	51.58	33.96	70.58	46.91

Competitive Comparison of Arterra Bioscience SpA's Gross Margin %

For the Biotechnology subindustry, Arterra Bioscience SpA's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arterra Bioscience SpA's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arterra Bioscience SpA's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Arterra Bioscience SpA's Gross Margin % falls into.

Save Embed

;

Save Embed

;

Arterra Bioscience SpA Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Arterra Bioscience SpA's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1.8	/	3.336
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(3.336 - 1.567)	/	3.336
	=	53.03 %

Arterra Bioscience SpA's Gross Margin for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )	=	Gross Profit (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	1.1	/	2.251
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(2.251 - 1.195)	/	2.251
	=	46.91 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Arterra Bioscience SpA (MIL:ARBS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Arterra Bioscience SpA had a gross margin of 46.91% for the quarter that ended in Jun. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Arterra Bioscience SpA Gross Margin % Related Terms

Thank you for viewing the detailed overview of Arterra Bioscience SpA's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arterra Bioscience SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arterra Bioscience SpA (MIL:ARBS) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

via Benedetto Brin, 69, Napoli, ITA, 80142

Website

https://www.arterrabio.it

Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.

Arterra Bioscience SpA Headlines

No Headlines